Novacyt (ALNOV) - Total Liabilities

Latest as of December 2025: €16.94 Million EUR ≈ $19.81 Million USD

Based on the latest financial reports, Novacyt (ALNOV) has total liabilities worth €16.94 Million EUR (≈ $19.81 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Novacyt (ALNOV) investment intensity to see how much of total assets are deployed in long-term investments.

Novacyt - Total Liabilities Trend (2008–2025)

This chart illustrates how Novacyt's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see ALNOV current and non-current assets.

Novacyt Competitors by Total Liabilities

The table below lists competitors of Novacyt ranked by their total liabilities.

Company	Country	Total Liabilities
Chi Hua Fitness Co Ltd TWO:1593	Taiwan	NT$688.93 Million
Arribatec Solutions ASA OL:ARR	Norway	Nkr168.17 Million
IHQ Inc KO:003560	Korea	₩40.85 Billion
Zaklady Przemyslu Cukierniczego Otmuchow S.A. WAR:OTM	Poland	zł64.22 Million
WT Financial Group Ltd AU:WTL	Australia	AU$26.32 Million
Corline Biomedical AB ST:CLBIO	Sweden	Skr15.18 Million
Chih Lien Industrial Co Ltd TW:2024	Taiwan	NT$495.04 Million

Liability Composition Analysis (2008–2025)

This chart breaks down Novacyt's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Novacyt net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.74	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.73	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.42	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Novacyt's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Novacyt (2008–2025)

The table below shows the annual total liabilities of Novacyt from 2008 to 2025.

Year	Total Liabilities	Change
2025-12-31	€16.94 Million ≈ $19.81 Million	-25.54%
2024-12-31	€22.75 Million ≈ $26.60 Million	-51.15%
2023-12-31	€46.57 Million ≈ $54.45 Million	+81.32%
2022-12-31	€25.68 Million ≈ $30.03 Million	-38.67%
2021-12-31	€41.88 Million ≈ $48.96 Million	-49.88%
2020-12-31	€83.57 Million ≈ $97.70 Million	+493.86%
2019-12-31	€14.07 Million ≈ $16.45 Million	+26.14%
2018-12-31	€11.16 Million ≈ $13.04 Million	+37.94%
2017-12-31	€8.09 Million ≈ $9.45 Million	-25.14%
2016-12-31	€10.80 Million ≈ $12.63 Million	+64.34%
2015-12-31	€6.57 Million ≈ $7.69 Million	+3.13%
2014-12-31	€6.37 Million ≈ $7.45 Million	+639.23%
2013-12-31	€862.25K ≈ $1.01 Million	-55.98%
2012-12-31	€1.96 Million ≈ $2.29 Million	-2.26%
2011-12-31	€2.00 Million ≈ $2.34 Million	-27.00%
2010-12-31	€2.75 Million ≈ $3.21 Million	+6.82%
2009-12-31	€2.57 Million ≈ $3.00 Million	+34.56%
2008-12-31	€1.91 Million ≈ $2.23 Million	--

About Novacyt

PA:ALNOV France Medical Devices

Market Cap

$40.81 Million

€34.91 Million EUR

Market Cap Rank

#22828 Global

#353 in France

Share Price

€0.48

Change (1 day)

+0.10%

52-Week Range

€0.32 - €0.90

All Time High

€13.24